Skip to content

A comparative study Kanchanar bark AND sunthi churna in the management of primary hypothyroidism

A Comparative study between Kanchanar (Bauhinia variegata linn.) bark kashaya With Sunthi(Zingiber officinale Roxb.) Churna and Levothyroxine in the management of primary hypothyroidism - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072767
Enrollment
60
Registered
2024-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Department of Health and Family Welfare Government of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants who are competent and willing to provide written informed consent. 2.Serum TSH levels more than 4.12 mIU/L 3.Serum FreeT4 level less than normal limit. 4.Patients who agreed to follow the study.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled diabetes mellitus, uncontrolled hypertension. 2. Lactating mother 3. Pregnant lady 4. Taking other hormonal therapy or pill. 5. Participants with evidence of malignancy. 6. Person who suffer any cardiac disease 7. Person recent received any surgical intervention 6. Person who take any anti-anxiety or depressive drug. 7. Secondary causes of hypothyroidism. 8. Patients who are not willing to include themselves under trial or give consent.

Design outcomes

Primary

MeasureTime frame
SERUM TSH will be assessedTimepoint: Every 4 weeks interval

Secondary

MeasureTime frame
Improve the quality of life by ZULEWSKI SCALE AND ThyPRO 39Timepoint: 90 days

Countries

India

Contacts

Public ContactSk Motiur Rahaman

The west bengal university of health sciences

dr.tapasbhaduri@gmail.com9836362763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026